Table 1. Clinical characteristics of the patients.
Characteristics | Patient data (n = 79) | |||
---|---|---|---|---|
Age (years) | 46.1±14.8 | |||
Gender | ||||
Male | 30 | |||
Female | 49 | |||
Hypertension | 15 | |||
Diabetes mellitus | 20 | |||
Chronic liver disease etiology | ||||
Alcoholic liver disease | 9 | |||
Chronic hepatitis B | 12 | |||
Chronic hepatitis C | 10 | |||
NAFLD | 42 | |||
others | 6 | |||
Body mass index (kg/m2) | 26.0±5.1 | |||
Waist circumference (cm) | 87.7±21.3 | |||
Total cholesterol (mg/mL) | 175.2±38.5 | |||
Triglyceride (mg/mL) | 148.6±112.7 | |||
HDL-cholesterol (mg/mL) | 48.7±16.8 | |||
LDL-cholesterol (mg/mL) | 105.1±38.8 | |||
AST (IU/L) | 68.0±51.0 | |||
ALT (IU/L) | 76.0±71.8 | |||
Total bilirubin (mg/dL) | 0.8±1.1 | |||
Serum albumin (g/dL) | 4.1±0.4 | |||
Platelet (103/μL) | 187.5±65.7 | |||
PT(INR) | 1.0±0.1 | |||
Liver histology | ||||
Steatosis | S0/S1/S2/S3 | 41/22/12/4 | ||
Metavir score | F0/F1/F2/F3/F4 | 10/22/23/15/9 | ||
Ultrasonography | ||||
normal/mild/moderate/severe | 32/21/15/11 | |||
CAP (dB/m, mean±SD) | 251.1±65.8 | |||
Liver stiffness value (kPa, mean±SD) | 12.8±10.6 |
NAFLD, non alcoholic fatty liver disease; AST, aspartate aminotransferase; ALT, alanine aminotrasferase; PT, prothrombin time; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CAP, controlled attenuation parameter; SD, standard deviation